On October 29, 2021, we held our International Mental Health Research Virtual Symposium.
Read More
The trend to legalize cannabis is not yet accompanied by a solid body of research that would assure the parents of an adolescent, for example, that the use of cannabis from an early age is harmless. Indeed, some recent research suggests that at least some young users may be at considerable mental health risk if they regularly ingest high-potency cannabis. Dr. Martin Paulus, a researcher and expert on how substance use affects the brain, explains what we know and don't know, and offers advice for parents of adolescents.
Read More
Research on COVID’s impacts indicates how the pandemic is affecting families and child mental health, as well as how racial and socioeconomic factors can exacerbate risk and pose obstacles to care for those who are underserved by the healthcare system.
Read More
In-depth discussion summarizing some of the most important findings to date about the possibility of using psychedelic compounds to treat individuals with psychiatric illness. We feature comments from experts in the field (several of them members of BBRF’s Scientific Council), who have been generally supportive, but careful, stressing what is known and what remains unknown about psychedelic-assisted psychiatric treatments. They have raised important questions about who should and should not be considered a candidate for such therapy and about the optimal conditions in which psychedelics should be administered.
Read More